newsfilter
← Latest News
PR Newswire·

AcelRx Pharmaceuticals Announces Publication of Results from an Investigator-Initiated Trial on Sufentanil Sublingual Tablet (SST) Compared to Standard Intravenous Opioids during Plastic Surgery Procedures Performed under General Anesthesia

Study found that SST lowered the opioid dose required by patients in the post-anesthesia care unit (PACU) by more than five-fold compared to standard intravenous opioid administration HAYWARD, Calif., May 10, 2022 /PRNewswire/ -- AcelRx Pharmaceutical